570 related articles for article (PubMed ID: 25777084)
1. Structurally-diverse, PPARγ-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells.
Watt J; Schlezinger JJ
Toxicology; 2015 May; 331():66-77. PubMed ID: 25777084
[TBL] [Abstract][Full Text] [Related]
2. Organotins are potent activators of PPARγ and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells.
Yanik SC; Baker AH; Mann KK; Schlezinger JJ
Toxicol Sci; 2011 Aug; 122(2):476-88. PubMed ID: 21622945
[TBL] [Abstract][Full Text] [Related]
3. Tributyltin engages multiple nuclear receptor pathways and suppresses osteogenesis in bone marrow multipotent stromal cells.
Baker AH; Watt J; Huang CK; Gerstenfeld LC; Schlezinger JJ
Chem Res Toxicol; 2015 Jun; 28(6):1156-66. PubMed ID: 25932594
[TBL] [Abstract][Full Text] [Related]
4. Ligand binding and activation of PPARγ by Firemaster® 550: effects on adipogenesis and osteogenesis in vitro.
Pillai HK; Fang M; Beglov D; Kozakov D; Vajda S; Stapleton HM; Webster TF; Schlezinger JJ
Environ Health Perspect; 2014 Nov; 122(11):1225-32. PubMed ID: 25062436
[TBL] [Abstract][Full Text] [Related]
5. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling.
Grün F; Blumberg B
Endocrinology; 2006 Jun; 147(6 Suppl):S50-5. PubMed ID: 16690801
[TBL] [Abstract][Full Text] [Related]
6. Alcohol-induced adipogenesis in a cloned bone-marrow stem cell.
Cui Q; Wang Y; Saleh KJ; Wang GJ; Balian G
J Bone Joint Surg Am; 2006 Nov; 88 Suppl 3():148-54. PubMed ID: 17079381
[TBL] [Abstract][Full Text] [Related]
7. PPARγ forms a bridge between DNA methylation and histone acetylation at the C/EBPα gene promoter to regulate the balance between osteogenesis and adipogenesis of bone marrow stromal cells.
Zhao QH; Wang SG; Liu SX; Li JP; Zhang YX; Sun ZY; Fan QM; Tian JW
FEBS J; 2013 Nov; 280(22):5801-14. PubMed ID: 23981481
[TBL] [Abstract][Full Text] [Related]
8. Plasticizer di(2-ethylhexyl)phthalate interferes with osteoblastogenesis and adipogenesis in a mouse model.
Chiu CY; Sun SC; Chiang CK; Wang CC; Chan DC; Chen HJ; Liu SH; Yang RS
J Orthop Res; 2018 Apr; 36(4):1124-1134. PubMed ID: 28921615
[TBL] [Abstract][Full Text] [Related]
9. Discovering small molecules that inhibit adipogenesis and promote osteoblastogenesis: unique screening and Oncostatin M-like activity.
Nawa K; Ikeno H; Matsuhashi N; Ogasawara T; Otsuka E
Differentiation; 2013; 86(1-2):65-74. PubMed ID: 23995451
[TBL] [Abstract][Full Text] [Related]
10. N-acetyl-L-cysteine enhances the osteogenic differentiation and inhibits the adipogenic differentiation through up regulation of Wnt 5a and down regulation of PPARG in bone marrow stromal cells.
Ji H; Liu Y; Zhao X; Zhang M
Biomed Pharmacother; 2011 Aug; 65(5):369-74. PubMed ID: 21775089
[TBL] [Abstract][Full Text] [Related]
11. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates.
Grün F; Watanabe H; Zamanian Z; Maeda L; Arima K; Cubacha R; Gardiner DM; Kanno J; Iguchi T; Blumberg B
Mol Endocrinol; 2006 Sep; 20(9):2141-55. PubMed ID: 16613991
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of transcription factor PPARγ and C/EBP family members during in vitro adipogenesis of human bone marrow mesenchymal stem cells.
Zhao XY; Chen XY; Zhang ZJ; Kang Y; Liao WM; Yu WH; Xiang AP
Cell Biol Int; 2015 Apr; 39(4):457-65. PubMed ID: 25523390
[TBL] [Abstract][Full Text] [Related]
13. PPARγ suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells.
Yu WH; Li FG; Chen XY; Li JT; Wu YH; Huang LH; Wang Z; Li P; Wang T; Lahn BT; Xiang AP
Int J Biochem Cell Biol; 2012 Feb; 44(2):377-84. PubMed ID: 22120652
[TBL] [Abstract][Full Text] [Related]
14. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters.
Hurst CH; Waxman DJ
Toxicol Sci; 2003 Aug; 74(2):297-308. PubMed ID: 12805656
[TBL] [Abstract][Full Text] [Related]
15. Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression.
Zhang L; Su P; Xu C; Chen C; Liang A; Du K; Peng Y; Huang D
J Pineal Res; 2010 Nov; 49(4):364-72. PubMed ID: 20738756
[TBL] [Abstract][Full Text] [Related]
16. Surface-specific effects of a PPARgamma agonist, darglitazone, on bone in mice.
Li M; Pan LC; Simmons HA; Li Y; Healy DR; Robinson BS; Ke HZ; Brown TA
Bone; 2006 Oct; 39(4):796-806. PubMed ID: 16759917
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of peroxisome proliferator-activated receptor-γ in steroid-induced adipogenic differentiation of the bone marrow mesenchymal stem cells of rabbit using small interference RNA.
Wang Y; Li J; Liu M; Zhao G; Hao L; Li Y
Chin Med J (Engl); 2014; 127(1):130-6. PubMed ID: 24384438
[TBL] [Abstract][Full Text] [Related]
18. S-nitrosoglutathione reductase-dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesis.
Cao Y; Gomes SA; Rangel EB; Paulino EC; Fonseca TL; Li J; Teixeira MB; Gouveia CH; Bianco AC; Kapiloff MS; Balkan W; Hare JM
J Clin Invest; 2015 Apr; 125(4):1679-91. PubMed ID: 25798618
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of adipogenic differentiation of bone marrow mesenchymal stem cells by erythropoietin via activating ERK and P38 MAPK.
Liu GX; Zhu JC; Chen XY; Zhu AZ; Liu CC; Lai Q; Chen ST
Genet Mol Res; 2015 Jun; 14(2):6968-77. PubMed ID: 26125905
[TBL] [Abstract][Full Text] [Related]
20. Methylparaben and butylparaben alter multipotent mesenchymal stem cell fates towards adipocyte lineage.
Hu P; Overby H; Heal E; Wang S; Chen J; Shen CL; Zhao L
Toxicol Appl Pharmacol; 2017 Aug; 329():48-57. PubMed ID: 28527915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
